VRE infections:
600 mg PO/IV Q12H x 14-28 days
Pneumonia, community-acquired:
600 mg PO/IV Q12H x 5 days
Pneumonia, hospital-acquired or ventilator-associated:
600 mg PO/IV Q12H x 5 days
Uncomplicated skin infections:
400 mg PO Q12H x 10-14 days
Complicated skin infections:
600 mg PO/IV Q12H x 10-14 days
Endocarditis
600 mg PO/IV Q12H x 6 weeks
600 mg PO/IV Q12H x 14-28 days
600 mg PO/IV Q12H x 5 days
600 mg PO/IV Q12H x 5 days
400 mg PO Q12H x 10-14 days
600 mg PO/IV Q12H x 10-14 days
600 mg PO/IV Q12H x 6 weeks
Linezolid
Meropenem
Teicoplanin
Vancomycin
Daptomycin
Ertapenem
Amikacin
Fosfomycin